- Lieber Memorial Teaching Associate Award (1976)
Dr. Brian L. Clevinger is currently a Managing Director at Prolog Ventures. He is also a founder of the firm and has 20 years of experience in all phases of commercial technology development.
Prior to this, he was the CEO at Megan Health; holding this position from the company's inception until its acquisition. Previously, he held a tenured position and headed a research laboratory at Washington University, where working with researchers, he evaluated numerous technologies, selected the most commercially promising ones for funding, and served on the Board of each resulting enterprise. Dr. Clevinger also learned the art of investing at an affiliate of Alafi Capital and then served as the founding Chief Executive Officer of a vaccine delivery company while at Washington University. He is a Director of AirXpanders, APT Therapeutics, Travanti, and ZyStor Therapeutics, and a Board Observer of Metaphore. He was a Director of Chlorogen.
He has completed a postdoctoral fellowship at Washington University and holds a Doctoral degree in Immunology from Indiana University.